Phase 2 Hodgkin's Lymphoma Clinical Trials
21 recruitingPhase 2
What is a Phase 2 trial?
Phase 2 trials evaluate whether a treatment works for a specific condition and further assess its safety. These studies typically enroll several hundred participants and provide preliminary data on effectiveness.
Showing 1–20 of 21 trials
Recruiting
Phase 2
Acalabrutinib With DA-EPOCH-R or R-CHOP for People With Untreated Diffuse Large B-cell Lymphoma
Non-Hodgkin's Lymphoma
National Cancer Institute (NCI)132 enrolled1 locationNCT04002947
Recruiting
Phase 2
A Phase II Study of the Combination of Azacitidine and Pembrolizumab for Patients Relapsed/Refractory Hodgkin's Lymphoma
Hodgkin's Lymphoma
M.D. Anderson Cancer Center24 enrolled1 locationNCT05355051
Recruiting
Phase 1Phase 2
A Dose Escalation Study of Glofitamab (RO7082859) as a Single Agent and in Combination With Obinutuzumab, Administered After a Fixed, Single Pre-treatment Dose of Obinutuzumab in Participants With Relapsed/Refractory B-cell Non-hodgkin's Lymphoma
Non-Hodgkin's Lymphoma
Hoffmann-La Roche940 enrolled38 locationsNCT03075696
Recruiting
Phase 2
MT2021-08T Cell Receptor Alpha/Beta Depletion PBSC Transplantation for Heme Malignancies
Acute Lymphoblastic LeukemiaAcute Myeloid LeukemiaAcute Leukemia+21 more
Masonic Cancer Center, University of Minnesota70 enrolled1 locationNCT05735717
Recruiting
Phase 1Phase 2
Study of Atezolizumab Plus BEGEV Regimen in Relapsed or Refractory Hodgkin's Lymphoma Patients
Relapsed or Refractory Hodgkin's Lymphoma
Fondazione Italiana Linfomi - ETS122 enrolled32 locationsNCT05300282
Recruiting
Phase 2
Epcoritamab and Rituximab for First-line Follicular Lymphoma
Follicular LymphomaLow Grade Non-Hodgkin's Lymphoma, Adult
Reid Merryman, MD100 enrolled5 locationsNCT05783609
Recruiting
Phase 2Phase 3
Role of Antibiotic Therapy or Immunoglobulin On iNfections in hAematoLogy Platform Trial (RATIONAL-PT)
LeukemiaMyelomaNon-Hodgkin's Lymphoma
Monash University900 enrolled3 locationsNCT07202052
Recruiting
Phase 2
JS203 Combination Regimens in B-Cell Non-Hodgkin's Lymphoma
B-cell Non-Hodgkin's Lymphoma
Shanghai Junshi Bioscience Co., Ltd.180 enrolled1 locationNCT07081022
Recruiting
Phase 1Phase 2
CLIC-1901 for the Treatment of Patients With Relapsed/Refractory CD19 Positive Hematologic Malignancies
Acute Lymphoblastic LeukemiaChronic Lymphocytic LeukemiaNon-Hodgkin's Lymphoma
Ottawa Hospital Research Institute60 enrolled3 locationsNCT03765177
Recruiting
Phase 1Phase 2
T-Cell Therapy (EB103) in Adults With Relapsed/Refractory B-Cell Non-Hodgkin's Lymphoma (NHL)
Non-Hodgkin LymphomaNon-Hodgkin's LymphomaLymphomas Non-Hodgkin's B-Cell+2 more
Estrella Biopharma, Inc.21 enrolled2 locationsNCT06343311
Recruiting
Phase 2
Phase II Clinical Trial of CNCT19 Cell Injection in the Treatment of Relapsed or Refractory Non-Hodgkin's Lymphoma
Non-Hodgkin's Lymphoma
Juventas Cell Therapy Ltd.60 enrolled17 locationsNCT04586478
Recruiting
Phase 1Phase 2
A Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Efficacy Study of MBS303 in B-Cell NHL
Non-Hodgkin's Lymphoma
Beijing Mabworks Biotech Co., Ltd.132 enrolled1 locationNCT05806099
Recruiting
Phase 1Phase 2
Chidamide Bridging for CAR-T Therapy
Non-Hodgkin's Lymphoma
Chinese PLA General Hospital120 enrolled13 locationsNCT05370547
Recruiting
Phase 1Phase 2
A Trial of SHR-A1912 Combined With Other Therapies in B-cell Non-Hodgkin 's Lymphoma
B-cell Non-Hodgkin's Lymphoma
Shanghai Hengrui Pharmaceutical Co., Ltd.132 enrolled1 locationNCT06104553
Recruiting
Phase 1Phase 2
Clinical Study of U16 in Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma
Relapsed or Refractory Non-Hodgkin's Lymphoma
Shanghai Unicar-Therapy Bio-medicine Technology Co.,Ltd100 enrolled2 locationsNCT05768529
Recruiting
Phase 2
Human CD19 Targeted T Cells Injection(CD19 CAR-T) Therapy for Relapsed and Refractory B-cell Non-Hodgkin's Lymphoma
B-cell Non-Hodgkin's Lymphoma
Hrain Biotechnology Co., Ltd.100 enrolled1 locationNCT05436223
Recruiting
Phase 1Phase 2
CD30-directed Chimeric Antigen Receptor T (CART30) Therapy in Relapsed and Refractory CD30 Positive Lymphomas
Hodgkin's LymphomaNon-Hodgkin's Lymphoma
Chinese PLA General Hospital30 enrolled1 locationNCT02259556
Terminated
Phase 2
Do gonadotrophin-releasing hormone (GnRH) agonists protect ovarian function in patients with Non-Hodgkin’s Lymphoma?
Ovarian function following chemotherapyNon-Hodgkin's Lymphoma
Melbourne in vitro fertilization (IVF)80 enrolled1 locationACTRN12610000785000
Recruiting
Phase 2
APO2L/TRAIL in Combination With Rituximab in Subjects Non-Hodgkin's Lymphoma
Non-Hodgkin's Lymphoma
Genentech105 enrolled2 locationsACTRN12608000627358
Active
Phase 2
A Study of Apomab in Combination With Rituximab in Patients With Non-Hodgkin's Lymphoma That Has Progressed Following Previous Rituximab Therapy
Non-Hodgkin's Lymphoma (NHL)
Genentech, Inc50 enrolled7 locationsACTRN12608000554369